Financhill
Buy
58

MLTX Quote, Financials, Valuation and Earnings

Last price:
$50.95
Seasonality move :
19.98%
Day range:
$49.00 - $51.04
52-week range:
$31.42 - $58.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.92x
Volume:
386.4K
Avg. volume:
666.8K
1-year change:
9.61%
Market cap:
$3.2B
Revenue:
--
EPS (TTM):
-$2.30

Earnings Data

Next earnings date for MLTX
Aug 07
2025
Most recent earnings per share
-$0.63
Beat by $0.11
(May 12/2025)
Consensus Estimate
-$0.74
(May 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MLTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -- -$0.78 --
08/07/2025 Q2 -- -- -- -$0.76 --
05/12/2025 Q1 -- -- -$0.63 -$0.74 $0.11
02/26/2025 Q4 -- -- -$0.72 -$0.59 -$0.13
11/07/2024 Q3 -- -- -$0.56 -$0.45 -$0.11
08/07/2024 Q2 -- -- -$0.39 -$0.28 -$0.11
05/07/2024 Q1 -- -- -$0.22 -$0.21 -$0.01
02/29/2024 Q4 -- -- -$0.10 -$0.27 $0.17
11/14/2023 Q3 -- -- -$0.18 -$0.25 $0.07
08/10/2023 Q2 -- -- -$0.23 -$0.29 $0.06
05/11/2023 Q1 -- -- -$0.23 -$0.29 $0.06
03/20/2023 Q4 -- -- -$0.31 -$0.28 -$0.03
11/14/2022 Q3 -- -- -$0.27 -- --
08/12/2022 Q2 -- -- -$0.34 -- --
03/31/2022 Q1 -- -- -$0.43 -- --
09/30/2021 Q3 -- -- -$0.17 -- --
06/30/2021 Q2 -- -- -$0.89 -- --

MoonLake Immunotherapeutics Earnings Questions

  • How Much did MoonLake Immunotherapeutics Generate in Revenue Last Quarter?

    MoonLake Immunotherapeutics reported -- worth of top line sales in its most recent quarter.

  • Did MoonLake Immunotherapeutics Beat Earnings Last Quarter?

    MoonLake Immunotherapeutics announced earnings per share of -$0.63 which represents a beat of analyst forecast a -$0.74 per share.

  • Is MoonLake Immunotherapeutics Profitable?

    MoonLake Immunotherapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for MoonLake Immunotherapeutics EPS Next Year?

    MoonLake Immunotherapeutics's earnings are forecast to decrease from -$1.89 per share to -$1.72 per share next year representing a decrease of -57.46%.

  • When is MoonLake Immunotherapeutics's Earnings Date?

    MoonLake Immunotherapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
INKT alert for Jul 15

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Sell
48
NEGG alert for Jul 15

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is up 19.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock